RxDoctor Payments Data

Chester Crump, MD

Family Medicine · Hopkinsville, KYNPI 1477528339

Payments from drug & device makers

$2,458in general payments, 2019–2025

Across 146 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$616
  • Amgen$292
  • Lilly USA, LLC$256
  • Novo Nordisk$220
  • AbbVie$193
  • Sanofi-aventis U.S. LLC$182
  • plus $700 from 14 others

What the payments were for

  • Food & beverage$2,458100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,458 in reported general payments places this provider in the 70th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$108,670
Medicare patients
221
Services billed
1,439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide151$150,658
TrulicityDulaglutide81$109,448
FarxigaDapagliflozin Propanediol88$84,021
RybelsusSemaglutide35$58,307
JardianceEmpagliflozin62$58,117
EliquisApixaban54$51,780
JanuviaSitagliptin Phosphate49$51,341
LinzessLinaclotide71$47,207
Soliqua 100-33Insulin Glargine/Lixisenatide28$45,762
MounjaroTirzepatide38$39,843
XareltoRivaroxaban36$29,899
EntrestoSacubitril/Valsartan17$17,618
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog27$16,112
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog36$13,342
VascepaIcosapent Ethyl18$11,603

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$220$208,964186 claims
Lilly USA, LLCTrulicity, Mounjaro$256$149,291119 claims
AstraZenecaFarxiga, Symbicort$616$87,591101 claims
Boehringer IngelheimJardiance$68$58,11762 claims
PfizerEliquis$140$51,78054 claims
AbbVieLinzess$193$47,20771 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$182$45,76228 claims
Johnson & JohnsonXarelto$42$29,89936 claims
NovartisEntresto$46$17,61817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Hopkinsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →